BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lopez-Lopez V, Robles-Campos R, Brusadin R, Lopez-Conesa A, de la Peña J, Caballero A, Arevalo-Perez J, Navarro-Barrios A, Gómez P, Parrilla-Paricio P. ALPPS for hepatocarcinoma under cirrhosis: a feasible alternative to portal vein embolization. Ann Transl Med 2019;7:691. [PMID: 31930092 DOI: 10.21037/atm.2019.10.57] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Cassese G, Troisi RI, Khayat S, Quenet F, Tomassini F, Panaro F, Guiu B. Liver venous deprivation versus associating liver partition and portal vein ligation for staged hepatectomy for colo-rectal liver metastases: a comparison of early and late kinetic growth rates, and perioperative and oncological outcomes. Surg Oncol 2022;43:101812. [PMID: 35820263 DOI: 10.1016/j.suronc.2022.101812] [Reference Citation Analysis]
2 Cheng J, Hong DF, Zhang CW, Fan XM, Luo ZY, Yao WF, Jin LM. Transcatheter arterial chemoembolization after percutaneous microwave ablation and portal vein embolization for advanced hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2022:S1499-3872(22)00145-X. [PMID: 35780016 DOI: 10.1016/j.hbpd.2022.06.013] [Reference Citation Analysis]
3 Lam T, Wong W, Lee C, Cheung C. Transarterial chemoembolisation plus stereotactic body radiotherapy as conversion therapy for large right lobe hepatocecullar carcinoma. Surgical Practice 2021;25:211-7. [DOI: 10.1111/1744-1633.12530] [Reference Citation Analysis]
4 Wang Q, Ji Y, Brismar TB, Chen S, Li C, Jiang J, Mu W, Zhang L, Sparrelid E, Ma K. Sequential Portal Vein Embolization and Percutaneous Radiofrequency Ablation for Future Liver Remnant Growth: A Minimally Invasive Alternative to ALPPS Stage-1 in Treatment of Hepatocellular Carcinoma. Front Surg 2021;8:741352. [PMID: 34660682 DOI: 10.3389/fsurg.2021.741352] [Reference Citation Analysis]
5 Beppu T, Yamamura K, Okabe H, Imai K, Hayashi H. Oncological benefits of portal vein embolization for patients with hepatocellular carcinoma. Ann Gastroenterol Surg 2021;5:287-95. [PMID: 34095718 DOI: 10.1002/ags3.12414] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Serenari M, Ratti F, Zanello M, Guglielmo N, Mocchegiani F, Di Benedetto F, Nardo B, Mazzaferro V, Cillo U, Massani M, Colledan M, Dalla Valle R, Cescon M, Vivarelli M, Colasanti M, Ettorre GM, Aldrighetti L, Jovine E. Minimally Invasive Stage 1 to Protect Against the Risk of Liver Failure: Results from the Hepatocellular Carcinoma Series of the Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy Italian Registry. J Laparoendosc Adv Surg Tech A 2020;30:1082-9. [PMID: 32907480 DOI: 10.1089/lap.2020.0563] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
7 Chan A, Kow A, Hibi T, Di Benedetto F, Serrablo A. Liver resection in Cirrhotic liver: Are there any limits? Int J Surg 2020;82S:109-14. [PMID: 32652296 DOI: 10.1016/j.ijsu.2020.06.050] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]